Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 5, 2011, Pages 447.e1-447.e8

  Roland, Katherine B ^a   Soman, Ashwini ^b   Benard, Vicki B ^a   Saraiya, Mona ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NORTHROP GRUMMAN CORPORATION   (United States)

Author keywords

cervical cancer screening; HPV test; screening guideline; screening interval

Indexed keywords

ADULT; AGED; CANCER SCREENING; FEMALE; HEALTH SURVEY; HUMAN; MEDICAL HISTORY; MEDICAL PRACTICE; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING INTERVAL; SCREENING TEST; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS; WART VIRUS TEST;

EID: 80255138895     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.06.001     Document Type: Article

References (32)

1. S.A. Cannistra, and J.M. Niloff Cancer of the uterine cervix N Engl J Med 334 1996 1030 1038 (Pubitemid 26123780)
2. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 2002 244 265 (Pubitemid 34293391)
3. N. Munoz, F.X. Bosch, and S. de Sanjose The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain Int J Cancer 52 1992 743 749
4. J.M.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
5. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 109: cervical cytology screening Obstet Gynecol 114 2009 1409 1420
6. J.T. Cox Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management Obstet Gynecol Surv 61 suppl 2006 S15 S25
7. D. Saslow, C.D. Runowicz, and D. Solomon American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 2002 342 362 (Pubitemid 35446606)
8. T.C. Wright Jr, M. Schiffman, and D. Solomon Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Obstet Gynecol 103 2004 304 309
9. C.P. Cooper, M. Saraiya, and T.A. McLean Report from the CDC: Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program J Womens Health (Larchmt) 14 2005 670 678 (Pubitemid 41645628)
10. P. Holland-Barkis, S.N. Forjuoh, G.R. Couchman, C. Capen, T.G. Rascoe, and M.D. Reis Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas Prev Med 42 2006 140 145 (Pubitemid 43207422)
11. H.I. Meissner, J.A. Tiro, K.R. Yabroff, D.A. Haggstrom, and S.S. Coughlin Too much of a good thing? Physician practices and patient willingness for less frequent Pap test screening intervals Med Care 48 2010 249 259
12. M. Saint, G. Gildengorin, and G.F. Sawaya Current cervical neoplasia screening practices of obstetrician/gynecologists in the United States Am J Obstet Gynecol 192 2005 414 421 (Pubitemid 40214973)
13. K.R. Yabroff, M. Saraiya, and H.I. Meissner Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007 Ann Intern Med 151 2009 602 611
14. M. Saraiya, Z. Berkowitz, K.R. Yabroff, L. Wideroff, S. Kobrin, and V. Benard Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med 170 2010 977 985
15. D.K. Cherry, E. Hing, D.A. Woodwell, and E.A. Rechtsteiner National Ambulatory Medical Care Survey: 2006 summary Natl Health Stat Report 3 2008 1 39
16. E. Hing, M.J. Hall, and J. Xu National Hospital Ambulatory Medical Care Survey: 2006 outpatient department summary Natl Health Stat Report 4 2008 1 31
17. Centers for Disease Control and Prevention, National Center for Health Statistics Cervical cancer screening supplement http://www.cdc.gov/nchs/data/ ahcd/namcsCCS-2006.pdf Accessed Feb. 24, 2011
18. Office of Management and Budget Standards and Guidelines for Statistical Surveys Response rate calculations, section 3.2, page 15 http://www.whitehouse. gov/sites/default/files/omb/inforeg/statpolicy/standards-stat-surveys.pdf Accessed Feb. 24, 2011
19. American College of Obstetricians and Gynecologists ACOG committee opinion no. 431: routine pelvic examination and cervical cytology screening Obstet Gynecol 113 2009 1190 1193
20. J.T. Cox The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology guidelines for the management of abnormal cervical cytology and cervical cancer precursors Arch Pathol Lab Med 127 2003 950 958 (Pubitemid 36994854)
21. R.A. Smith, V. Cokkinides, and O.W. Brawley Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin 59 2009 27 41
22. T.C. Wright Jr, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, and D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical screening tests J Low Genit Tract Dis 11 2007 201 222 (Pubitemid 47530909)
23. American College of Obstetricians and Gynecologists ACOG practice bulletin, no. 45: cervical cytology screening Int J Gynaecol Obstet 83 2003 237 247
24. P.E. Castle, M. Sideri, J. Jeronimo, D. Solomon, and M. Schiffman Risk assessment to guide the prevention of cervical cancer J Low Genit Tract Dis 12 2008 1 7
25. J. Salmeron, E. Lazcano-Ponce, and A. Lorincz Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico Cancer Causes Control 14 2003 505 512 (Pubitemid 36999965)
26. G.F. Sawaya Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone." Arch Intern Med 170 2010 985 986
27. K.B. Roland, T.L. Larkins, V.B. Benard, Z. Berkowitz, and M. Saraiya Content analysis of continuing medical education for cervical cancer screening J Womens Health (Larchmt) 19 2010 651 657
28. S.J. Henley, J.B. King, R.R. German, L.C. Richardson, and M. Plescia Surveillance of screening-detected cancers (colon and rectum, breast, and cervix): United States, 2004-2006 MMWR Surveill Sum 59 2010 1 25
29. T.R. Dresselhaus, J.W. Peabody, J. Luck, and D. Bertenthal An evaluation of vignettes for predicting variation in the quality of preventive care J Gen Intern Med 19 2004 1013 1018 (Pubitemid 39431137)
30. J.W. Peabody, J. Luck, P. Glassman, T.R. Dresselhaus, and M. Lee Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality JAMA 283 2000 1715 1722 (Pubitemid 30196212)
31. J.W. Peabody, J. Luck, and P. Glassman Measuring the quality of physician practice by using clinical vignettes: a prospective validation study Ann Intern Med 141 2004 771 780
32. D. Solomon, N. Breen, and T. McNeel Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines CA Cancer J Clin 57 2007 105 111 (Pubitemid 46535710)